Vol 3-Issue 3


Editorial

The Broad Avenue of Therapeutic Ketosis in Neurodegenerative and Metabolism-Related Pathologies

The Ketogenic Diet (KD) represents a well-known therapeutic option for refractory epilepsy [1], although mechanisms regulating its anticonvulsant effects still remain partially unknown [2].

Published 15 Jun, 2018


Editorial

Angiotensin II for Vasodilatory Shock: Is it Ready for Prime Time?

More than 1.5 million people in the United States are diagnosed with sepsis every year, with approximately 250,000 people dying of sepsis [1].

Published 16 Jun, 2018


Short Communication

Abaloparatide: Future Projects

After fifteen years of studies, in 2017 the Food and Drug Administration approved a new osteoanabolic drug, Abaloparatide (ABL), with the indication of the treatment of post-menopausal osteoporosis in women at high risk of fracture, i.e. with history of fragility fracture, multiple risk factors or unable to assume other anti-osteoporosis drugs for intolerance or inefficacy [1].

Published 16 Jun, 2018


Short Communication

The Chemoprevention and Chemotherapy of Ginger in Prostate Cancer

Cancer is one of the major causes of death in the world. Prostate cancer is common cancer in western countries.

Published 15 Jun, 2018


Review Article

Portulaca Oleracea Phytochemistry and Pharmacological Considerations

Purslane (Portulaca oleracea), is edible both fresh and prepared. It also has therapeutic properties being mentioned, of Dioscorides in the list of herbs, used by, in the past, under the name of lax.

Published 06 Jun, 2018





SHARE THIS ARTICLE


Renowned Editors

MIT, John Hopkins University, Stanford University, University of Michigan...300+

Rapid Peer Review

We assure 20 days rapid peer review process

Open Access

Open Access is the free, immediate, online availability of novel research

High Visibility

Published articles are easy to find on google, google scholar and other databases